Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders

Lian Zeng,Pengchao Hu,Yu Zhang,Mingyue Li,Yilin Zhao,Shiyong Li,Ailin Luo
DOI: https://doi.org/10.1016/j.cytogfr.2024.03.003
IF: 17.66
2024-03-01
Cytokine & Growth Factor Reviews
Abstract:Macrophage migration inhibitory factor (MIF) is a cytokine in the immune system, participated in both innate and adaptive immune responses. Except from immune cells, MIF is also secreted by a variety of non-immune cells, including hematopoietic cells, endothelial cells (ECs), and neurons. MIF plays a crucial role in various diseases, such as sepsis, rheumatoid arthritis, acute kidney injury, and neurodegenerative diseases. The role of MIF in the neuropathogenesis of cognitive impairment disorders is emphasized, as it recruits multiple inflammatory mediators, leading to activating microglia or astrocyte-derived neuroinflammation. Furthermore, it contributes to the cell death of neurons and ECs with the binding of apoptosis-inducing factor (AIF) through parthanatos-associated apoptosis-inducing factor nuclease (PAAN) / MIF pathway. This review comprehensively delves into the relationship between MIF and the neuropathogenesis of cognitive impairment disorders, providing a series of emerging MIF-targeted pharmaceuticals as potential treatments for cognitive impairment disorders.
biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?